标题
Therapy Development by Genome Editing of Hematopoietic Stem Cells
作者
关键词
-
出版物
Cells
Volume 10, Issue 6, Pages 1492
出版商
MDPI AG
发表日期
2021-06-14
DOI
10.3390/cells10061492
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells
- (2021) Norman F. Russkamp et al. EXPERIMENTAL HEMATOLOGY
- Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
- (2021) Paula Cannon et al. HUMAN GENE THERAPY
- CRISPR-based strategies in infectious disease diagnosis and therapy
- (2021) Alexandra Binnie et al. INFECTION
- Precision genome editing using cytosine and adenine base editors in mammalian cells
- (2021) Tony P. Huang et al. Nature Protocols
- Ionizable lipid nanoparticles for in utero mRNA delivery
- (2021) Rachel S. Riley et al. Science Advances
- Enhanced Homology-directed Repair for Highly Efficient Gene Editing in Hematopoietic Stem/Progenitor Cells
- (2021) Suk See De Ravin et al. BLOOD
- Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq
- (2021) Giandomenico Turchiano et al. Cell Stem Cell
- Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases
- (2021) Akira Nishimura et al. JOURNAL OF CLINICAL IMMUNOLOGY
- In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice
- (2021) Chang Li et al. Blood Advances
- Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
- (2021) James K. Nuñez et al. CELL
- Automated production of CCR5-negative CD4+-T cells in a GMP-compatible, clinical scale for treatment of HIV-positive patients
- (2021) Lea Isabell Schwarze et al. GENE THERAPY
- A Consensus Model of Homology-Directed Repair Initiated by CRISPR/Cas Activity
- (2021) Kevin Bloh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
- (2021) Mitchell L. Leibowitz et al. NATURE GENETICS
- A short overview of CRISPR-Cas technology and its application in viral disease control
- (2021) Abozar Ghorbani et al. TRANSGENIC RESEARCH
- Improving the Precision of Base Editing by Bubble Hairpin Single Guide RNA
- (2021) Zhiwei Hu et al. mBio
- A Small Molecule-Controlled Cas9 Repressible System
- (2020) Youjun Wu et al. Molecular Therapy-Nucleic Acids
- Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
- (2020) Hua Alexander Han et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Therapeutic base editing of human hematopoietic stem cells
- (2020) Jing Zeng et al. NATURE MEDICINE
- Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
- (2020) Russell T. Walton et al. SCIENCE
- Graft Versus Host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft Versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta Thalassemia Major with Busulfan, Fludarabine, and Thiotepa
- (2020) Pooja Khandelwal et al. TRANSPLANTATION
- Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repair
- (2020) Beeke Wienert et al. Nature Communications
- CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cells
- (2020) M. Goodwin et al. Science Advances
- Uncertainty in an era of transformative therapy for haemophilia: Addressing the unknowns
- (2020) Glenn F. Pierce HAEMOPHILIA
- Hemophilia gene therapy—New country initiatives
- (2020) Ulrike M. Reiss et al. HAEMOPHILIA
- Gene therapy for X-linked severe combined immunodeficiency: Historical outcomes and current status
- (2020) Sung-Yun Pai et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Drug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens
- (2020) Emanuel Gonçalves et al. Molecular Systems Biology
- Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
- (2020) Andrew V. Anzalone et al. NATURE BIOTECHNOLOGY
- Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
- (2020) Samuele Ferrari et al. NATURE BIOTECHNOLOGY
- Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome
- (2020) Rajeev Rai et al. Nature Communications
- Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives
- (2020) Selami Demirci et al. Stem Cells Translational Medicine
- Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells
- (2020) Michael A. Morgan et al. Frontiers in Immunology
- Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID
- (2020) Laura Garcia-Perez et al. Molecular Therapy-Methods & Clinical Development
- CRISPR-Directed Therapeutic Correction at the NCF1 Locus Is Challenged by Frequent Incidence of Chromosomal Deletions
- (2020) Dominik Wrona et al. Molecular Therapy-Methods & Clinical Development
- CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich’s Ataxia
- (2020) Celine J. Rocca et al. Molecular Therapy-Methods & Clinical Development
- Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing
- (2020) Muhammad Naeem et al. Cells
- CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma
- (2020) Peter Makhov et al. BRITISH JOURNAL OF CANCER
- In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model
- (2020) Chang Li et al. MOLECULAR THERAPY
- Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy
- (2020) Alejandra Gutierrez-Guerrero et al. Viruses-Basel
- The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology
- (2020) Luis Apolonia Viruses-Basel
- A Rad51-independent pathway promotes single-strand template repair in gene editing
- (2020) Danielle N. Gallagher et al. PLoS Genetics
- PRDM8 reveals aberrant DNA methylation in aging syndromes and is relevant for hematopoietic and neuronal differentiation
- (2020) Olivia Cypris et al. Clinical Epigenetics
- CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
- (2020) Mohammadreza Azangou-Khyavy et al. Frontiers in Immunology
- Purification of Human CD34+CD90+ HSCs Reduces Target Cell Population and Improves Lentiviral Transduction for Gene Therapy
- (2020) Stefan Radtke et al. Molecular Therapy-Methods & Clinical Development
- Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements
- (2020) Hongjie Wang et al. JCI Insight
- Gene therapy for primary immunodeficiencies
- (2020) Thomas A. Fox et al. BRITISH JOURNAL OF HAEMATOLOGY
- Gene therapy using haematopoietic stem and progenitor cells
- (2020) Giuliana Ferrari et al. NATURE REVIEWS GENETICS
- Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease
- (2020) Erica B. Esrick et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
- (2020) Haydar Frangoul et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precision control of CRISPR-Cas9 using small molecules and light
- (2019) Soumyashree Ashok Gangopadhyay et al. BIOCHEMISTRY
- Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia
- (2019) Sarah Marktel et al. NATURE MEDICINE
- Ex Vivo Expansion of Hematopoietic Stem Cells for Therapeutic Purposes: Lessons from Development and the Niche
- (2019) Parisa Tajer et al. Cells
- TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction
- (2019) Christopher T. Lux et al. Molecular Therapy-Methods & Clinical Development
- Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8+ T Cell Responses
- (2019) Céline Cousin et al. Cell Reports
- Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation
- (2019) Agnieszka Czechowicz et al. Nature Communications
- Highly efficient therapeutic gene editing of human hematopoietic stem cells
- (2019) Yuxuan Wu et al. NATURE MEDICINE
- Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
- (2019) Giulia Schiroli et al. Cell Stem Cell
- Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia
- (2019) Shuqian Xu et al. BLOOD
- Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases
- (2019) Daesik Kim et al. Annual Review of Biochemistry
- CRISPR/Cas9-modified hematopoietic stem cells—present and future perspectives for stem cell transplantation
- (2019) Alberto Daniel-Moreno et al. BONE MARROW TRANSPLANTATION
- Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019
- (2019) Rafael F. Duarte et al. BONE MARROW TRANSPLANTATION
- Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas- and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells
- (2019) Petros Patsali et al. HAEMATOLOGICA
- Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
- (2019) Petros Patsali et al. Molecular Diagnosis & Therapy
- Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases
- (2019) Panayiota Papasavva et al. Molecular Diagnosis & Therapy
- Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors
- (2019) Tony P. Huang et al. NATURE BIOTECHNOLOGY
- Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations
- (2019) Reza Shahbazi et al. NATURE MATERIALS
- Universal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR/Cas9
- (2019) Chul-Yong Park et al. Stem Cell Reports
- Enhancement of Precise Gene Editing by the Association of Cas9 With Homologous Recombination Factors
- (2019) Ngoc-Tung Tran et al. Frontiers in Genetics
- Gene therapy of hematological disorders: current challenges
- (2019) Amr M. Al-Saif GENE THERAPY
- Busulfan Combined with Immunosuppression Allows Efficient Engraftment of Gene-Modified Cells in a Rhesus Macaque Model
- (2019) Naoya Uchida et al. MOLECULAR THERAPY
- Therapeutically relevant engraftment of a CRISPR-Cas9–edited HSC-enriched population with HbF reactivation in nonhuman primates
- (2019) Olivier Humbert et al. Science Translational Medicine
- NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia
- (2019) Francisco José Román-Rodríguez et al. Cell Stem Cell
- Hematopoietic stem cell gene therapy for brain metastases using myeloid cell-specific gene promoters
- (2019) Tereza Andreou et al. JNCI-Journal of the National Cancer Institute
- Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia
- (2019) Paula Río et al. NATURE MEDICINE
- Pooled CRISPR-Based Genetic Screens in Mammalian Cells
- (2019) Katherine Chan et al. Jove-Journal of Visualized Experiments
- Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
- (2019) Sabine Charrier et al. Molecular Therapy-Methods & Clinical Development
- Differential transgene silencing of myeloid-specific promoters in the AAVS1 safe harbor locus of iPSC-derived myeloid cells
- (2019) Denise Klatt et al. HUMAN GENE THERAPY
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia
- (2019) Sachith Mettananda et al. Scientific Reports
- Hemophilia A ameliorated in mice by CRISPR-based in vivo genome editing of human Factor VIII
- (2019) Hainan Chen et al. Scientific Reports
- The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements
- (2019) Petros Patsali et al. Journal of Clinical Medicine
- Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
- (2019) Mara Pavel-Dinu et al. Nature Communications
- Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine
- (2018) Hyokyoung Kwon et al. BIOMATERIALS
- Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
- (2018) Chiara Antoniani et al. BLOOD
- Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing
- (2018) Chang Li et al. BLOOD
- Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34 + Hematopoietic Stem and Progenitor Cells
- (2018) M. Kyle Cromer et al. MOLECULAR THERAPY
- Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements
- (2018) Michael Kosicki et al. NATURE BIOTECHNOLOGY
- CRISPR–Cas9 genome editing in human cells occurs via the Fanconi anemia pathway
- (2018) Chris D. Richardson et al. NATURE GENETICS
- p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
- (2018) Robert J. Ihry et al. NATURE MEDICINE
- CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
- (2018) Emma Haapaniemi et al. NATURE MEDICINE
- CRISPR/Cas9 genome editing in human hematopoietic stem cells
- (2018) Rasmus O Bak et al. Nature Protocols
- Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
- (2018) Alexis A. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells
- (2018) Tafadzwa Mlambo et al. NUCLEIC ACIDS RESEARCH
- Emerging applications of genome-editing technology to examine functionality of GWAS-associated variants for complex traits
- (2018) Andrew J. P. Smith et al. PHYSIOLOGICAL GENOMICS
- Gene therapy comes of age
- (2018) Cynthia E. Dunbar et al. SCIENCE
- CRISPR/Cas9 for cancer research and therapy
- (2018) Tianzuo Zhan et al. SEMINARS IN CANCER BIOLOGY
- Engineering circular RNA for potent and stable translation in eukaryotic cells
- (2018) R. Alexander Wesselhoeft et al. Nature Communications
- Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
- (2018) Caroline Y. Kuo et al. Cell Reports
- Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
- (2018) Vijaya L. Simhadri et al. Molecular Therapy-Methods & Clinical Development
- UM171 enhances lentiviral gene transfer and recovery of primitive human hematopoietic cells
- (2018) Mor Ngom et al. Molecular Therapy-Methods & Clinical Development
- Advances in the Gene Therapy of Fanconi Anemia
- (2018) Paula Río et al. HUMAN GENE THERAPY
- Reprogramming human T cell function and specificity with non-viral genome targeting
- (2018) Theodore L. Roth et al. NATURE
- An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities
- (2018) Jason M Gehrke et al. NATURE BIOTECHNOLOGY
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans
- (2018) Serena Scala et al. NATURE MEDICINE
- Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major
- (2018) Nikoletta Psatha et al. Molecular Therapy-Methods & Clinical Development
- In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia
- (2018) Hongjie Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Genome-edited baby claim provokes international outcry
- (2018) David Cyranoski et al. NATURE
- Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA Repair
- (2018) Anastasia Lomova et al. STEM CELLS
- European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience
- (2017) A. T. van der Ploeg et al. EUROPEAN JOURNAL OF NEUROLOGY
- AAV: An Overview of Unanswered Questions
- (2017) Kenneth I. Berns et al. HUMAN GENE THERAPY
- CRISPR/Cas9-mediated somatic and germline gene correction to restore hemostasis in hemophilia B mice
- (2017) Cong Huai et al. HUMAN GENETICS
- CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells
- (2017) Karolina Skvarova Kramarzova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing
- (2017) Jianguo Wen et al. Journal of Hematology & Oncology
- CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein
- (2017) Lichun Tang et al. MOLECULAR GENETICS AND GENOMICS
- Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction
- (2017) Colin L. Sweeney et al. MOLECULAR THERAPY
- Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells
- (2017) Katelyn E. Masiuk et al. MOLECULAR THERAPY
- CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo
- (2017) Lei Xu et al. MOLECULAR THERAPY
- Refining strategies to translate genome editing to the clinic
- (2017) Tatjana I Cornu et al. NATURE MEDICINE
- Gene Therapy in a Patient with Sickle Cell Disease
- (2017) Jean-Antoine Ribeil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
- (2017) Florian Eichler et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease
- (2017) Suk See De Ravin et al. Science Translational Medicine
- Transplantation of wild-type mouse hematopoietic stem and progenitor cells ameliorates deficits in a mouse model of Friedreich’s ataxia
- (2017) Celine J. Rocca et al. Science Translational Medicine
- Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1
- (2017) Giulia Schiroli et al. Science Translational Medicine
- Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
- (2017) Sachith Mettananda et al. Nature Communications
- CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice
- (2017) Tsukasa Ohmori et al. Scientific Reports
- CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors
- (2017) Rasmus O. Bak et al. Cell Reports
- Correction of β-thalassemia mutant by base editor in human embryos
- (2017) Puping Liang et al. Protein & Cell
- Brief Report: A Differential Transcriptomic Profile of Ex Vivo Expanded Adult Human Hematopoietic Stem Cells Empowers Them for Engraftment Better than Their Surface Phenotype
- (2017) Nikoletta Psatha et al. Stem Cells Translational Medicine
- A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease
- (2017) Liuhong Cai et al. Stem Cells Translational Medicine
- Advances in Non-Viral DNA Vectors for Gene Therapy
- (2017) Cinnamon Hardee et al. Genes
- One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection
- (2017) Yali Liu et al. Molecular Therapy-Nucleic Acids
- Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy
- (2017) Erika Zonari et al. Stem Cell Reports
- Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34 + Hematopoietic Stem and Progenitor Cells
- (2017) Kai-Hsin Chang et al. Molecular Therapy-Methods & Clinical Development
- Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos
- (2017) Zhuchi Tu et al. Scientific Reports
- From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation
- (2016) Rosa Bacchetta et al. Annals of the New York Academy of Sciences
- Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome
- (2016) Nicholas Hubbard et al. BLOOD
- Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing
- (2016) Angelo Amabile et al. CELL
- In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases
- (2016) Luca Biasco et al. Cell Stem Cell
- Autologous Stem Cell Mobilization and Collection
- (2016) Yen-Michael S. Hsu et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Combining Single Strand Oligodeoxynucleotides and CRISPR/Cas9 to Correct Gene Mutations in β-Thalassemia-induced Pluripotent Stem Cells
- (2016) Xiaohua Niu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic disruption of theKLF1gene to overexpress the γ-globin gene using the CRISPR/Cas9system
- (2016) Laleh Shariati et al. JOURNAL OF GENE MEDICINE
- Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial
- (2016) Maria Sessa et al. LANCET
- CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
- (2016) Megan D Hoban et al. MOLECULAR THERAPY
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
- (2016) Daniel P. Dever et al. NATURE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease
- (2016) Suk See De Ravin et al. NATURE BIOTECHNOLOGY
- A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
- (2016) Elizabeth A Traxler et al. NATURE MEDICINE
- Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
- (2016) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency
- (2016) Suk See De Ravin et al. Science Translational Medicine
- Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
- (2016) M. A. DeWitt et al. Science Translational Medicine
- RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency
- (2016) Jun Song et al. Nature Communications
- In situ genetic correction of F8 intron 22 inversion in hemophilia A patient-specific iPSCs
- (2016) Yong Wu et al. Scientific Reports
- Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair
- (2016) Tony Gutschner et al. Cell Reports
- Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases
- (2016) Carmen F Bjurström et al. Molecular Therapy-Nucleic Acids
- Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects
- (2016) Tamara J. Laskowski et al. Stem Cell Reports
- The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice
- (2016) Zhanhui Ou et al. Scientific Reports
- TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells
- (2015) Anne-Kathrin Dreyer et al. BIOMATERIALS
- Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
- (2015) M. D. Hoban et al. BLOOD
- Faster T-cell development following gene therapy compared with haploidentical HSCT in the treatment of SCID-X1
- (2015) F. Touzot et al. BLOOD
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- Plerixafor+G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy
- (2015) G. Karponi et al. BLOOD
- Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9
- (2015) Chul-Yong Park et al. Cell Stem Cell
- CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells
- (2015) Rowan Flynn et al. EXPERIMENTAL HEMATOLOGY
- Fanconi Anemia Gene Editing by the CRISPR/Cas9 System
- (2015) Mark J. Osborn et al. HUMAN GENE THERAPY
- Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome
- (2015) Salima Hacein-Bey Abina et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection
- (2015) Xiquan Liang et al. JOURNAL OF BIOTECHNOLOGY
- An AAVS1-Targeted Minigene Platform for Correction of iPSCs From All Five Types of Chronic Granulomatous Disease
- (2015) Randall K Merling et al. MOLECULAR THERAPY
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
- (2015) Matthew C. Canver et al. NATURE
- Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
- (2015) Takeshi Maruyama et al. NATURE BIOTECHNOLOGY
- Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
- (2015) Jianbin Wang et al. NATURE BIOTECHNOLOGY
- Enrichment of Human Hematopoietic Stem/Progenitor Cells Facilitates Transduction for Stem Cell Gene Therapy
- (2015) Kismet Baldwin et al. STEM CELLS
- Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation
- (2015) Xiaosong Huang et al. STEM CELLS
- Improved Hematopoietic Differentiation Efficiency of Gene-Corrected Beta-Thalassemia Induced Pluripotent Stem Cells by CRISPR/Cas9 System
- (2015) Bing Song et al. STEM CELLS AND DEVELOPMENT
- Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs
- (2015) Peng Xu et al. Scientific Reports
- Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting
- (2015) Chia-Wei Chang et al. Cell Reports
- Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9
- (2015) Yuanyuan Yang et al. Stem Cells Translational Medicine
- Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation
- (2015) Kamola Saydaminova et al. Molecular Therapy-Methods & Clinical Development
- Genome Engineering with Targetable Nucleases
- (2014) Dana Carroll Annual Review of Biochemistry
- Targeted gene therapy and cell reprogramming in Fanconi anemia
- (2014) P. Rio et al. EMBO Molecular Medicine
- Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 andpiggyBac
- (2014) Fei Xie et al. GENOME RESEARCH
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
- (2014) S. Kim et al. GENOME RESEARCH
- Gene Therapy for Hemoglobinopathies
- (2014) Shanmuganathan Chandrakasan et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Targeted genome editing in human repopulating haematopoietic stem cells
- (2014) Pietro Genovese et al. NATURE
- Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases
- (2014) Richard L Frock et al. NATURE BIOTECHNOLOGY
- mRNA-based therapeutics — developing a new class of drugs
- (2014) Ugur Sahin et al. NATURE REVIEWS DRUG DISCOVERY
- TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity
- (2014) Claudio Mussolino et al. NUCLEIC ACIDS RESEARCH
- IthaGenes: An Interactive Database for Haemoglobin Variations and Epidemiology
- (2014) Petros Kountouris et al. PLoS One
- Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENs
- (2014) C.-Y. Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Winding Road to Pluripotency (Nobel Lecture)
- (2013) Shinya Yamanaka ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Genome Engineering with TAL-Effector Nucleases and Alternative Modular Nuclease Technologies
- (2013) Andrew Scharenberg et al. CURRENT GENE THERAPY
- Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases
- (2013) S. W. Cho et al. GENOME RESEARCH
- B-cell function after unrelated umbilical cord blood transplantation using a minimal-intensity conditioning regimen in patients with X-SCID
- (2013) Satoru Kumaki et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Transcription Activator-like Effector Nuclease (TALEN)-mediated Gene Correction in Integration-free β-Thalassemia Induced Pluripotent Stem Cells
- (2013) Ning Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
- (2013) A. Aiuti et al. SCIENCE
- CD4+ T Cells from IPEX Patients Convert into Functional and Stable Regulatory T Cells by FOXP3 Gene Transfer
- (2013) L. Passerini et al. Science Translational Medicine
- Reawakening fetal hemoglobin: prospects for new therapies for the -globin disorders
- (2012) D. E. Bauer et al. BLOOD
- RNA-guided genetic silencing systems in bacteria and archaea
- (2012) Blake Wiedenheft et al. NATURE
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease
- (2011) J. Zou et al. BLOOD
- Meganucleases and Other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene Therapy
- (2011) George Silva et al. CURRENT GENE THERAPY
- Cell cycle regulation in hematopoietic stem cells
- (2011) Eric M. Pietras et al. JOURNAL OF CELL BIOLOGY
- Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects
- (2011) Evangelia Yannaki et al. MOLECULAR THERAPY
- In vivo genome editing restores haemostasis in a mouse model of haemophilia
- (2011) Hojun Li et al. NATURE
- An unbiased genome-wide analysis of zinc-finger nuclease specificity
- (2011) Richard Gabriel et al. NATURE BIOTECHNOLOGY
- Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment
- (2011) F. Notta et al. SCIENCE
- In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger Nucleases
- (2011) Vittorio Sebastiano et al. STEM CELLS
- A zinc-finger transcriptional activator designed to interact with the -globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts
- (2010) A. Wilber et al. BLOOD
- Update on the hyper immunoglobulin M syndromes
- (2010) E. Graham Davies et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and Mutagenesis
- (2010) Mary Mohrin et al. Cell Stem Cell
- The majority of the in vitro erythroid expansion potential resides in CD34- cells, outweighing the contribution of CD34+ cells and significantly increasing the erythroblast yield from peripheral blood samples
- (2010) E. van den Akker et al. HAEMATOLOGICA
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
- (2010) Marina Cavazzana-Calvo et al. NATURE
- Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
- (2010) Stefan Stein et al. NATURE MEDICINE
- Genome editing with engineered zinc finger nucleases
- (2010) Fyodor D. Urnov et al. NATURE REVIEWS GENETICS
- FDA Review Summary: Mozobil in Combination with Granulocyte Colony-Stimulating Factor to Mobilize Hematopoietic Stem Cells to the Peripheral Blood for Collection and Subsequent Autologous Transplantation
- (2010) Michael Brave et al. ONCOLOGY
- Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells
- (2010) Anthony E. Boitano et al. SCIENCE
- Removal of B cell epitopes as a practical approach for reducing the immunogenicity of foreign protein-based therapeutics☆
- (2009) Satoshi Nagata et al. ADVANCED DRUG DELIVERY REVIEWS
- Primary immunodeficiencies
- (2009) Luigi D. Notarangelo JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease
- (2009) Matthew M. Hsieh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
- (2009) N. Cartier et al. SCIENCE
- Recent Advances in Bone Marrow Transplantation in Hemoglobinopathies
- (2008) Jennifer Michlitsch et al. CURRENT MOLECULAR MEDICINE
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
- (2008) Steven J. Howe et al. JOURNAL OF CLINICAL INVESTIGATION
- Modulation of biodistribution and expression of plasmid DNA following mesenchymal progenitor cell-based delivery
- (2008) Young-Sin Jeong et al. JOURNAL OF DRUG TARGETING
- Globin Lentiviral Vector Insertions Can Perturb the Expression of Endogenous Genes in β-thalassemic Hematopoietic Cells
- (2008) Phillip W Hargrove et al. MOLECULAR THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started